One of the cheapest cards in Magic: The Gathering's new Marvel set just turned into one of its hottest singles. Doctor Octopus, Master Planner has climbed from $1.80 to $8.80 in a matter of days, close to a 400% jump, and the strange part is that Spider-Man has almost nothing to do with it.
Doc Ock is a Spider-Man villain, sure, and the card comes straight out of the Marvel Super Heroes set that hit shelves on June 26th. But nobody is paying up because they want to build a Spidey deck. They want him for Doctor Doom.
For seven mana, the good doctor does three things at once. He hands every other villain you control a +2/+2 buff. He bumps your maximum hand size up to eight. And at the end of each of your turns, he draws you back up to eight cards. On his own he's a 4/8 body, which is a lot of beef to sit behind while you refill.
That last part is why the price moved. The most popular of the new Marvel Commander precons by a wide margin is Doom Prevails, fronted by Doctor Doom, King of Latveria. Doom's whole game plan leans on discarding and looting your own cards to fuel his schemes, so you spend a lot of turns dumping your hand on purpose. A card that lets you completely refill to eight every turn is the safety net that deck wants.
Players noticed fast. EDHREC now lists Doctor Octopus in 46% of logged Doctor Doom decks, a huge adoption rate for a seven-drop that isn't even the commander. When nearly half the builds of the format's hottest deck all want the same $2 card, that card doesn't stay $2 for long.
Wargamer's Matt Bassil flagged the spike on July 13th, pointing at MTGGoldfish data that had the card running from $1.80 up to $8.80. That's nearly five times what it cost at release, and a move like that usually takes a card months, not a couple of weeks.
Marvel Super Heroes is one of the biggest releases in Magic's history, a roughly 270-card Universes Beyond set that went Standard-legal and drew a ban inside its first week. A $500,000 Pro Tour runs in Amsterdam from July 17th to 19th, so the whole format is under a microscope right now. Doc Ock is just the latest single to catch fire.
If you've watched Magic finances at all over the past few years, this rhythm should feel familiar. Universes Beyond crossovers keep pulling in buyers who don't normally sleeve up, the same way the Lord of the Rings set did back in 2023. When a franchise brings in fresh money, the cards those new players want most can move on demand alone, well ahead of anything the competitive scene is doing.
Some singles-market context: crossover sets like this one tend to live and die on their Commander cards, and the biggest spikes almost always trace back to a precon a lot of people bought and then went looking to upgrade. Cheap role-players that slot into a popular commander are where the real money tends to move, long after the mythic rares have settled into their prices.
One thing to keep in mind - Spikes driven by a single deck can retrace just as fast, especially if Wizards reprints the card in a future set or a Commander product down the line. A card sitting in 46% of decks tells you it's wanted right now. It doesn't promise it will hold $8.80 six months from now.
So the real question for collectors and speculators is a familiar one. If you already own a copy or two, is this the peak to sell into, or the start of a longer climb as more people build Doom Prevails? Still shopping for your first copy? At $8.80, is that a fair buy-in, or do you wait out the hype and bet on a reprint?
Let us know where you land on Doctor Octopus in the comments below!
Related GameFragger Coverage